JasonEliFarrarMDFAAP(He/Him)
Pediatric Hematology & Oncology • Little Rock, ARAssociate Professor, Pediatrics, University of Arkansas COM
Dr. Farrar is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1 Children's Way
MS 512-10
Little Rock, AR 72202Phone+1 501-364-1494
Summary
- Dr. Jason Farrar is a pediatric hematologist/oncologist in Little Rock, AR and is affiliated with Arkansas Children's Hospital and UAMS Medical Center. He received his medical degree from University of Arkansas for Medical Sciences (UAMS) College of Medicine, completed residency training at Children's Hospital of Wisconsin, and hematology/oncology fellowship at Johns Hopkins and the National Cancer Institute. He has been in practice 21 years. He is experienced in bone marrow failure syndromes, acute myeloid leukemia, acute lymphoblastic leukemia, and pediatric hematologic oncology. He has more than 40 publications and over 2000 citations.
Education & Training
Johns Hopkins UniversityFellowship, Pediatric Hematology/Oncology, 2003 - 2007
Pediatric Oncology Branch, National Cancer InstitutePediatric Oncology, Pediatric Oncology, 2003 - 2006
Medical College of Wisconsin Affiliated HospitalsResidency, Pediatrics, 2000 - 2003
University of Arkansas For Medical Sciences College of MedicineClass of 2000
Certifications & Licensure
AR State Medical License 2012 - 2025
MD State Medical License 2003 - 2012
WI State Medical License 2001 - 2007- American Board of Pediatrics Pediatric Hematology-Oncology
Clinical Trials
- A Phase II Dose-escalation Study Characterizing the PK of Eltrombopag in Pediatric Patients With Previously Untreated or Relapsed Severe Aplastic Anemia or Recurrent Aplastic Anemia Start of enrollment: 2017 Sep 30
- A Trial Comparing Unrelated Donor BMT With IST for Pediatric and Young Adult Patients With Severe Aplastic Anemia (TransIT, BMT CTN 2202) Start of enrollment: 2023 Jan 25
Roles: Contact
Publications & Presentations
PubMed
- 25 citationsIncreased Prevalence of Congenital Heart Disease in Children With Diamond Blackfan Anemia Suggests Unrecognized Diamond Blackfan Anemia as a Cause of Congenital Heart ...Adrianna Vlachos, Diana S Osorio, Evangelia Atsidaftos, Jessica Kang, Mohammad Lutfi Lababidi
Circulation. Genomic and Precision Medicine. 2018-05-01 - 48 citationsCSF3R mutations have a high degree of overlap with CEBPA mutations in pediatric AMLJulia E. Maxson, Rhonda E. Ries, Yi-Cheng Wang, Robert B. Gerbing, E. Anders Kolb
Blood. 2016-06-16 - 239 citationsThe molecular landscape of pediatric acute myeloid leukemia reveals recurrent structural alterations and age-specific mutational interactions.Hamid Bolouri, Jason E Farrar, Timothy Triche Jr, Rhonda E Ries, Emilia L Lim
Nature Medicine. 2018-01-01
Abstracts/Posters
- Structural Variants Involving MLLT10/AF10 Are Associated with Adverse Outcome in AML Regardless of the Partner Gene _ a COG/Tpaml StudyJason E. Farrar, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Discovery of Novel IL3RA (CD123) Isoforms By Long Read Transcriptomics, Heterogeneous Expression Among AML Patient Cohorts and the Implications for Anti-CD123 Therapeu...Jason E. Farrar, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Long Non-Coding RNAs (lncRNAs) Are Highly Associated with Disease Characteristics and Outcome in Pediatric Acute Myeloid Leukemia _ a COG and Tpaml StudyJason E. Farrar, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Join now to see all
Press Mentions
- Arkansas Children's Hospital Becomes Nation's First Therapeutic Site in Launch of Groundbreaking Clinical Trial for Pediatric Acute LeukemiaJune 29th, 2022
‘Remarkable’ Distinctions in Pediatric Leukemia Point Toward Improved TreatmentFebruary 1st, 2023
Grant Support
- Mechanisms of Erythroid Remission in Diamond Blackfan AnemiaNational Heart, Lung, And Blood Institute2020–2023
- Center for Pediatric Translational ResearchNational Institute of General Medical Sciences2017–2020
- Functional Analysis Of Rpl35a Alterations In Diamond Blackfan AnemiaNational Heart, Lung, And Blood Institute2009–2012
Professional Memberships
- Member
- Fellow
- American Society of Pediatric Hematology OncologyMember
- Society for Pediatric ResearchMember
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
